Search results

Publication date Communities Collections Article title Author(s) Journal/Conference
7 Aug 2025 Others Experimental Drug Development Centre Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 M<sup>pro</sup> Inhibitor with Pan-Coronavirus Activity (Pending publish) Qian Wen Tan, Subramanyam Vankadara, Jia Yi Fong, Yi Yang See, Nithya Baburajendran, Pearly Shuyi Ng, Weijun Xu, Yee Khoon Yeo, Weiling Wang, Choon Heng Low, Li Hong Tan, Eileen Gui Ju Tay, Yun Xuan Wong, Chuhui Huang, Sandra Sim, Shi Hua Ang, Hannah Hui Min Toh, Juliana Mohammad, Gang Wang, Boping Liu, Shu Ting Tan, Perlyn Zekui Kwek, Monique Danielle Dawson, Qin Yao Oh, Xiaoying Koh, Joma Joy, May Ann Lee, Walter Stunkel, Vishal Pendharkar, Hannes Hentze, Siew Pheng Lim, Kantharaj Ethirajulu, C. S. Brian Chia, Joseph Cherian Journal of Medicinal Chemistry
18 Jul 2014 BMRC Institute of Molecular and Cell Biology Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers Lawrence S. Lee, Jenny G.H. Low, Eng Eong Ooi, Kantharaj Ethirajulu, Pauline Yeo, Alex Matter, John E. Connolly, David A.G. Skibinski, Philippe Saudan, Martin Bachmann, Brendon J. Hanson, Qingshu Lu, Sebastian Maurer-Stroh, Sam Lim, Veronica Novotny-Diermayr Vaccine